ArticleAging2020
SMARCD3 is a potential prognostic marker and therapeutic target in CAFs.
Ming Jiang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papercites it
ArticleAging2020
Ming Jiang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.